Skip to main content
Livermore
Livermore
ZHEN

HighTower Advisors, LLC

SEC CIK
0001462245
Latest filing
Aug 25, 2026

TAK holding history

Takeda Pharmaceutical Co Ltd in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TAK overviewAll 13F holders of TAKFull Q2 2026 holdings

Shares (Q2 2026)
95,466
Value
$1.53M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TAK by HighTower Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202695,466$1.53M<0.1%−7,616−7.4%ReducedHolders
Q1 2026103,082$1.91M<0.1%+8,254+8.7%AddedHolders
Q4 202594,828$1.48M<0.1%−4,014−4.1%ReducedHolders
Q3 202598,842$1.45M<0.1%+2,517+2.6%AddedHolders
Q2 202596,325$1.49M<0.1%+8,580+9.8%AddedHolders
Q1 202587,745$1.30M<0.1%−36,694−29.5%ReducedHolders
Q4 2024124,439$1.65M<0.1%+1,852+1.5%AddedHolders
Q3 2024122,587$1.74M<0.1%+81,653+199.5%AddedHolders
Q2 202440,934$532.0K<0.1%−52,123−56.0%ReducedHolders
Q1 202493,057$1.30M<0.1%+8,787+10.4%AddedHolders
Q4 202384,270$1.21M<0.1%+550+0.7%AddedHolders
Q3 202383,720$1.30M<0.1%+12,423+17.4%AddedHolders
Q2 202371,297$1.12M<0.1%+38,651+118.4%AddedHolders
Q1 202332,646$523.0K<0.1%+6,204+23.5%AddedHolders
Q4 202226,442$414.0K<0.1%+3,015+12.9%AddedHolders
Q3 202223,427$304.0K<0.1%−719−3.0%ReducedHolders
Q2 202224,146$340.0K<0.1%−4,180−14.8%ReducedHolders
Q1 202228,326$404.0K<0.1%+1,973+7.5%AddedHolders
Q4 202126,353$360.0K<0.1%−5,260−16.6%ReducedHolders
Q3 202131,613$512.0K<0.1%−611−1.9%ReducedHolders
Q2 202132,224$544.0K<0.1%+5,666+21.3%AddedHolders
Q1 202126,558$485.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.